AZMIRO

Peak

testosterone cypionate

NDAINTRAMUSCULARSOLUTION
Approved
Jun 2022
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2

Mechanism of Action

androgens, including testosterone and dihydrotestosterone (DHT), are responsible for normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include growth and maturation of the prostate, seminal vesicles, penis, and scrotum; the…

Clinical Trials (2)

NCT04558866Phase 2Active Not Recruiting

Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)

Started Jun 2021
51 enrolled
Prostate Cancer
NCT03792477Phase 1Completed

A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males

Started Jan 2019
74 enrolled
Hypogonadism

Loss of Exclusivity

LOE Date
Mar 25, 2039
159 months away
Patent Expiry
Mar 25, 2039

Patent Records (3)

Patent #ExpiryTypeUse Code
11311554
Mar 25, 2039
Product
11642355
Mar 25, 2039
Product
12138271
Mar 25, 2039
Product